Orladeyo (berotralstat) / BioCryst, Royalty  >>  Phase 1
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Orladeyo (berotralstat) / BioCryst
NCT02448264: First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BCX7353 in Healthy Western and Japanese Volunteers

Completed
1
122
Europe
BCX7353, Placebo to match BCX7353
BioCryst Pharmaceuticals
Hereditary Angioedema
11/15
12/15
NCT02819102: An Open-label Drug-Drug Interaction Study to Evaluate the Effect of BCX7353 on Cytochrome P450 Enzyme Activity Using Probe Substrates

Completed
1
20
Europe
BCX7353 and probes
BioCryst Pharmaceuticals
Hereditary Angioedema
06/16
06/16
NCT03202784: A Relative Bioavailability Study of Two Formulations of BCX7353

Completed
1
24
Europe
BCX7353
BioCryst Pharmaceuticals
Hereditary Angioedema
08/17
09/17
NCT03136237: A Drug-Drug Interaction Study to Evaluate Drug Transporter Interactions

Completed
1
54
Europe
BCX7353, Digoxin, BCX7353 + digoxin, Rosuvastatin, rosuvastatin + BCX7353, Cyclosporine + BCX7353
BioCryst Pharmaceuticals
Hereditary Angioedema
08/17
08/17

Download Options